Published in N Engl J Med on March 28, 1974
Protective antigen and toxin neutralization antibody patterns in anthrax vaccinees undergoing serial plasmapheresis. Clin Diagn Lab Immunol (2005) 0.98
The contribution of virology to contemporary medicine. Br J Prev Soc Med (1975) 0.93
Problems of protection against virus B hepatitis. Postgrad Med J (1976) 0.87
Antiviral therapy. Yale J Biol Med (1978) 0.81
Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection. J Gastroenterol (2016) 0.76
Passive immunization against exposure to hepatitis B virus in the military: potential and possibilities. Yale J Biol Med (1976) 0.75
Current concepts of viral hepatitis and a peek into the future. Yale J Biol Med (1974) 0.75
Use of immunoglobulin with high content of antibody to hepatitis B surface antigen (anti-HBs). Working Party on the Clinical Use of Specific Immunoglobulin in Hepatitis B. Br Med J (Clin Res Ed) (1982) 0.75
Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med (1980) 9.34
An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A (1968) 7.33
Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol (1978) 5.02
Embryonic epsilon and gamma globin genes of a prosimian primate (Galago crassicaudatus). Nucleotide and amino acid sequences, developmental regulation and phylogenetic footprints. J Mol Biol (1988) 4.75
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
On the role of sexual behavior in the spread of hepatitis B infection. Ann Intern Med (1975) 4.11
Serum hepatitis antigen (SH): rapid detection by high voltage immunoelectroosmophoresis. Science (1970) 4.00
Contraindicated use of cisapride: impact of food and drug administration regulatory action. JAMA (2000) 3.81
Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer (1976) 3.79
Locus control regions of mammalian beta-globin gene clusters: combining phylogenetic analyses and experimental results to gain functional insights. Gene (1997) 3.77
Phylogenetic footprinting reveals a nuclear protein which binds to silencer sequences in the human gamma and epsilon globin genes. Mol Cell Biol (1992) 3.57
Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci U S A (1991) 3.34
The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol (1977) 3.07
Darwinian evolution in the genealogy of haemoglobin. Nature (1975) 3.00
The role of circulating hepatitis B antigen/antibody immune complexes in the pathogenesis of vascular and hepatic manifestations in polyarteritis nodosa. J Clin Pathol (1974) 2.85
Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet (1974) 2.77
A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology (1982) 2.74
Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide. Proc Natl Acad Sci U S A (1982) 2.52
Phylogenetic relations of humans and African apes from DNA sequences in the psi eta-globin region. Science (1987) 2.48
Decoding the pattern of protein evolution. Prog Biophys Mol Biol (1981) 2.46
Evolution of nuclear- and mitochondrial-encoded subunit interaction in cytochrome c oxidase. Mol Biol Evol (2001) 2.36
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol (2000) 2.33
Molecular evolution of the psi eta-globin gene locus: gibbon phylogeny and the hominoid slowdown. Mol Biol Evol (1991) 2.33
Multifocal multiphoton microscopy. Opt Lett (1998) 2.31
Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med (1981) 2.29
Primate eta-globin DNA sequences and man's place among the great apes. Nature (1986) 2.27
Molecular evolution of cytochrome c oxidase subunit I in primates: is there coevolution between mitochondrial and nuclear genomes? Mol Phylogenet Evol (2000) 2.26
Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet (1992) 2.25
Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology (1983) 2.22
Hepatitis A virus infection: new insights from seroepidemiologic studies. J Infect Dis (1978) 2.21
Comparison of five methods for finding conserved sequences in multiple alignments of gene regulatory regions. Nucleic Acids Res (1999) 2.19
Evolutionary strategies for the elucidation of cis and trans factors that regulate the developmental switching programs of the beta-like globin genes. Mol Phylogenet Evol (1996) 2.17
Immunologic distinction between infectious and serum hepatitis. N Engl J Med (1970) 2.16
The sin of Onan. J R Soc Med (2000) 2.15
Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res (1989) 2.14
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
Evolution of EF-hand calcium-modulated proteins. I. Relationships based on amino acid sequences. J Mol Evol (1990) 2.12
HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol (1979) 2.06
Comparative lipoplasty analysis of in vivo-treated adipose tissue. Plast Reconstr Surg (2000) 2.05
Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res (1988) 2.02
A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med (1971) 2.02
Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med (1984) 2.01
Using an age-sex register. J R Coll Gen Pract (1975) 2.00
3-(Diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one (DEPBT): a new coupling reagent with remarkable resistance to racemization. Org Lett (1999) 1.97
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med (1984) 1.93
Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. JAMA (1974) 1.92
Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis-B antigen. Lancet (1973) 1.89
The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol (1977) 1.86
Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol (2000) 1.86
Role of serum hepatitis virus in chronic liver disease. Gastroenterology (1971) 1.84
Evidence on mammalian phylogeny from sequences of exon 28 of the von Willebrand factor gene. Mol Phylogenet Evol (1996) 1.83
Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res (1990) 1.83
Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey. J Virol (1991) 1.82
Distribution of antibody to hepatitis a antigen in urban adult populations. N Engl J Med (1976) 1.81
Climate change and the integrity of science. Science (2010) 1.80
Assault on a GP. Br Med J (Clin Res Ed) (1987) 1.80
Relation of Australia and SH antigens. Lancet (1968) 1.75
Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis (1982) 1.74
Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance. Gut (1976) 1.74
Rejection of the "flying primate" hypothesis by phylogenetic evidence from the epsilon-globin gene. Science (1992) 1.74
Phylogenetic origins and adaptive evolution of avian and mammalian haemoglobin genes. Nature (1982) 1.70
Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing. Vaccine (1986) 1.68
Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med (1975) 1.66
Molecular systematics of higher primates: genealogical relations and classification. Proc Natl Acad Sci U S A (1988) 1.66
Recent advances in the study of the epidemiology of hepatitis B. Am J Pathol (1975) 1.64
Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. Proc Natl Acad Sci U S A (1989) 1.64
Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection. J Infect Dis (1993) 1.63
Regulated processing of hepatitis C virus core protein is linked to subcellular localization. J Virol (1997) 1.63
Familial clustering of hepatitis B infection. N Engl J Med (1973) 1.56
Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation (1990) 1.55
Prevalence of antibody to the Norwalk virus in various countries. Infect Immun (1979) 1.54
High affinity YY1 binding motifs: identification of two core types (ACAT and CCAT) and distribution of potential binding sites within the human beta globin cluster. Nucleic Acids Res (1995) 1.52
The eta-globin gene. Its long evolutionary history in the beta-globin gene family of mammals. J Mol Biol (1984) 1.52
S.H. antigen and chronic liver disease. Lancet (1970) 1.51
A molecular view of primate phylogeny and important systematic and evolutionary questions. Mol Biol Evol (1989) 1.50
Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis (2013) 1.50
Photon irradiation of unresectable carcinomas of salivary glands. Int J Radiat Oncol Biol Phys (1991) 1.49
The spatial distribution of fixed mutations within genes coding for proteins. J Mol Evol (1983) 1.49
Duplication of the gamma-globin gene mediated by L1 long interspersed repetitive elements in an early ancestor of simian primates. Proc Natl Acad Sci U S A (1991) 1.48
VENTRICULAR ENDOMYOCARDIAL CHANGES AFTER IMPAIRMENT OF CARDIAC LYMPH FLOW IN DOGS. Br Heart J (1963) 1.48
Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res (1988) 1.48
Intrafamilial spread of asymptomatic hepatitis B. Am J Med Sci (1977) 1.48
Prevention of HIV-1 IIIB infection in chimpanzees by CD4 immunoadhesin. Nature (1991) 1.47
Hepatitis B antigen and antibody in blood donors: an epidemiologic study. J Infect Dis (1973) 1.46
Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. N Engl J Med (1982) 1.46
The use of tri(n-butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation. Transfusion (1990) 1.45
A molecular perspective on mammalian evolution from the gene encoding interphotoreceptor retinoid binding protein, with convincing evidence for bat monophyly. Mol Phylogenet Evol (1992) 1.45
Gamma-glutamyltransferase as a potential surrogate marker for detection of the non-A, non-B carrier state. Vox Sang (1988) 1.44
The epidemiology of hepatitis B infections in Africa: results of a pilot survey in the Republic of Senegal. Am J Epidemiol (1973) 1.43
Prevalence of serum-hepatitis-related antigen (SH) in different geographic regions. Am J Trop Med Hyg (1970) 1.42